You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

Investigational Drug Information for Mapracorat


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Mapracorat?

Mapracorat is an investigational drug.

There have been 12 clinical trials for Mapracorat. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Inflammation, Cataract, and Eczema. The leading clinical trial sponsors are Bausch & Lomb Incorporated, Bayer, and [disabled in preview].

Recent Clinical Trials for Mapracorat
TitleSponsorPhase
1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratBayerPhase 1
Corneal Endothelial Cell Density Changes, When Mapracorat Ophthalmic Suspension 3%, is Administered for 14 DaysBausch & Lomb IncorporatedPhase 1
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryBausch & Lomb IncorporatedPhase 3

See all Mapracorat clinical trials

Clinical Trial Summary for Mapracorat

Top disease conditions for Mapracorat
Top clinical trial sponsors for Mapracorat

See all Mapracorat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.